ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
MannKind and United Therapeutics NDA for Tyvaso DPI™ Accepted by U.S. FDA
June 18, 2021MannKind Corporation and United Therapeutics Corporation announced that the U.S. FDA accepted for priority review the New Drug Application (NDA) for Tyvaso DPI™ (inhaled treprostinil) for the treatment of pulmonary arterial hypertension (PAH) and ... -
United Therapeutics Announces FDA Acceptance of Trevyent New Drug Application For Review
September 16, 2019United Therapeutics Corporation announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for Trevyent® (treprostinil) for the treatment of pulmonary...
Pharma Sources Insight January 2025
